$AWH
Aspira Women's Health Inc.

2021 Q3 Form 10-Q Financial Statement

#000092661721000069 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $1.666M $1.799M $746.0K
YoY Change 34.46% 141.15% -34.68%
Cost Of Revenue $917.0K $1.103M $593.0K
YoY Change 13.63% 86.0% -34.69%
Gross Profit $749.0K $696.0K $153.0K
YoY Change 73.38% 354.9% -34.62%
Gross Profit Margin 44.96% 38.69% 20.51%
Selling, General & Admin $8.922M $7.297M $3.599M
YoY Change 116.66% 102.75% -16.57%
% of Gross Profit 1191.19% 1048.42% 2352.29%
Research & Development $1.518M $1.471M $380.0K
YoY Change 155.13% 287.11% 68.89%
% of Gross Profit 202.67% 211.35% 248.37%
Depreciation & Amortization $66.00K $82.00K $50.00K
YoY Change -5.71% 64.0% -50.0%
% of Gross Profit 8.81% 11.78% 32.68%
Operating Expenses $10.44M $8.768M $3.979M
YoY Change 121.51% 120.36% -12.34%
Operating Profit -$9.691M -$8.072M -$3.826M
YoY Change 126.37% 110.98% -11.13%
Interest Expense -$14.00K $3.000K $0.00
YoY Change -240.0%
% of Operating Profit
Other Income/Expense, Net -$2.000K $995.0K -$6.000K
YoY Change -81.82% -16683.33% -14.29%
Pretax Income -$9.707M -$7.074M -$3.830M
YoY Change 126.27% 84.7% -11.14%
Income Tax
% Of Pretax Income
Net Earnings -$9.707M -$7.074M -$3.831M
YoY Change 126.43% 84.65% -11.2%
Net Earnings / Revenue -582.65% -393.22% -513.54%
Basic Earnings Per Share -$0.09 -$0.06
Diluted Earnings Per Share -$86.61K -$0.06 -$39.03K
COMMON SHARES
Basic Shares Outstanding 112.1M 112.0M 97.38M
Diluted Shares Outstanding 112.1M 112.0M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.87M $52.99M $10.90M
YoY Change 138.67% 386.17% -32.72%
Cash & Equivalents $44.87M $52.99M $10.94M
Short-Term Investments
Other Short-Term Assets $1.078M $740.0K $900.0K
YoY Change 115.6% -17.78% 80.0%
Inventory $137.0K $101.0K $100.0K
Prepaid Expenses
Receivables $1.103M $1.073M $800.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $47.19M $54.91M $12.70M
YoY Change 133.02% 332.34% -27.7%
LONG-TERM ASSETS
Property, Plant & Equipment $498.0K $546.0K $400.0K
YoY Change -50.2% 36.5% -15.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $41.00K
YoY Change -100.0% -64.35%
Total Long-Term Assets $859.0K $922.0K $391.0K
YoY Change -15.29% 135.81% -33.39%
TOTAL ASSETS
Total Short-Term Assets $47.19M $54.91M $12.70M
Total Long-Term Assets $859.0K $922.0K $391.0K
Total Assets $48.05M $55.83M $13.09M
YoY Change 125.94% 326.47% -27.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.155M $1.436M $1.122M
YoY Change -12.17% 27.99% 38.35%
Accrued Expenses $4.998M $3.900M $2.459M
YoY Change 77.55% 58.6% -0.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $204.0K $587.0K
YoY Change -100.0% -65.25% 207.33%
Long-Term Debt Due $200.0K $199.0K
YoY Change
Total Short-Term Liabilities $6.409M $5.791M $4.199M
YoY Change 39.33% 37.91% 17.92%
LONG-TERM LIABILITIES
Long-Term Debt $2.768M $2.818M $1.615M
YoY Change 62.82% 74.49% 35.03%
Other Long-Term Liabilities $366.0K $382.0K $10.00K
YoY Change -8.5% 3720.0% -65.52%
Total Long-Term Liabilities $2.768M $2.818M $1.625M
YoY Change 31.81% 73.42% 32.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.409M $5.791M $4.199M
Total Long-Term Liabilities $2.768M $2.818M $1.625M
Total Liabilities $9.543M $8.991M $5.824M
YoY Change 42.43% 54.38% 21.69%
SHAREHOLDERS EQUITY
Retained Earnings -$462.8M -$453.1M -$429.7M
YoY Change 6.63% 5.44% 3.55%
Common Stock $112.0K $112.0K $101.0K
YoY Change 10.89% 7.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.50M $46.84M $7.267M
YoY Change
Total Liabilities & Shareholders Equity $48.05M $55.83M $13.09M
YoY Change 125.57% 326.47% -27.88%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$9.707M -$7.074M -$3.831M
YoY Change 126.43% 84.65% -11.2%
Depreciation, Depletion And Amortization $66.00K $82.00K $50.00K
YoY Change -5.71% 64.0% -50.0%
Cash From Operating Activities -$8.001M -$6.485M -$3.410M
YoY Change 160.62% 90.18% -3.67%
INVESTING ACTIVITIES
Capital Expenditures -$18.00K -$96.00K -$100.0K
YoY Change -88.0% -4.0% 233.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$18.00K -$96.00K -$100.0K
YoY Change -88.0% -4.0% 233.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 146.0K 213.0K 6.320M
YoY Change -98.69% -96.63% -53.46%
NET CHANGE
Cash From Operating Activities -8.001M -6.485M -3.410M
Cash From Investing Activities -18.00K -96.00K -100.0K
Cash From Financing Activities 146.0K 213.0K 6.320M
Net Change In Cash -7.873M -6.368M 2.810M
YoY Change -199.78% -326.62% -71.93%
FREE CASH FLOW
Cash From Operating Activities -$8.001M -$6.485M -$3.410M
Capital Expenditures -$18.00K -$96.00K -$100.0K
Free Cash Flow -$7.983M -$6.389M -$3.310M
YoY Change 173.39% 93.02% -5.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q2 us-gaap Assets
Assets
55829000
CY2020Q4 us-gaap Assets
Assets
19605000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1436000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Entity Central Index Key
EntityCentralIndexKey
0000926617
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34810
dei Entity Registrant Name
EntityRegistrantName
Aspira Women’s Health Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0595156
dei Entity Address Address Line1
EntityAddressAddressLine1
12117 Bee Caves Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Building Three
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78738
dei City Area Code
CityAreaCode
512
dei Local Phone Number
LocalPhoneNumber
519-0400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
AWH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
112067034
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52993000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16631000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1073000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
865000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
740000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1077000
CY2021Q2 us-gaap Inventory Net
InventoryNet
101000
CY2020Q4 us-gaap Inventory Net
InventoryNet
30000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
54907000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
18603000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
546000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
583000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
376000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
406000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1103000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3900000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3618000
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
199000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
645000
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
204000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
611000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5791000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6000000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2818000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3477000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
382000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
409000
CY2021Q2 us-gaap Liabilities
Liabilities
8991000
CY2020Q4 us-gaap Liabilities
Liabilities
9886000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112058034
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112058034
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
104619876
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104619876
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
112000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
105000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
499786000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
449680000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-453060000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-440066000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
46838000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9719000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55829000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19605000
CY2021Q2 us-gaap Revenues
Revenues
1799000
CY2020Q2 us-gaap Revenues
Revenues
746000
us-gaap Revenues
Revenues
3295000
us-gaap Revenues
Revenues
1966000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1103000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
593000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1996000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1393000
CY2021Q2 us-gaap Gross Profit
GrossProfit
696000
CY2020Q2 us-gaap Gross Profit
GrossProfit
153000
us-gaap Gross Profit
GrossProfit
1299000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3848000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3279000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1866000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5788000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3576000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
8768000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
3979000
us-gaap Gross Profit
GrossProfit
573000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1471000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
380000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2343000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
775000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4018000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1733000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7126000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7074000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3831000
us-gaap Net Income Loss
NetIncomeLoss
-12994000
us-gaap Net Income Loss
NetIncomeLoss
-7537000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
111958928
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
98123789
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
110311666
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
97707904
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9719000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5920000
us-gaap Operating Expenses
OperatingExpenses
15257000
us-gaap Operating Expenses
OperatingExpenses
8199000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8072000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3826000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13958000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7626000
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
995000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
985000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
317000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47720000
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
489000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
52325000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7074000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
304000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
267000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1015000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
46838000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8738000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3706000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2020Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
269000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5302000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3831000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
295000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
121000
CY2020Q2 awh Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
5060000
CY2020Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
320000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
7267000
us-gaap Net Income Loss
NetIncomeLoss
-12994000
us-gaap Net Income Loss
NetIncomeLoss
-7537000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
172000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
114000
us-gaap Share Based Compensation
ShareBasedCompensation
1771000
us-gaap Share Based Compensation
ShareBasedCompensation
710000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
awh Forgiveness Of Paycheck Protection Program Loan
ForgivenessOfPaycheckProtectionProgramLoan
1006000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
208000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-105000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-350000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
99000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
41000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
208000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-165000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11745000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6911000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
123000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-123000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
99000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
96000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
621000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
296000
awh Proceeds From Paycheck Protection Program Loan
ProceedsFromPaycheckProtectionProgramLoan
1006000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5060000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48236000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
515000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48243000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6266000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36362000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-768000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16631000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11703000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52993000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10935000
us-gaap Interest Paid Net
InterestPaidNet
38000
us-gaap Interest Paid Net
InterestPaidNet
18000
awh Net Increase In Right Of Use Assets
NetIncreaseInRightOfUseAssets
-30000
awh Net Increase In Right Of Use Assets
NetIncreaseInRightOfUseAssets
11000
awh Minimum Percentage Reduction Of False Elevations By Ova1plus
MinimumPercentageReductionOfFalseElevationsByOva1plus
0.40
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-453060000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
3017000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
4122000
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
199000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
645000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2818000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3477000
CY2021Q2 us-gaap Contractual Obligation
ContractualObligation
3034000
CY2021Q2 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
101000
CY2021Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
204000
CY2021Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
406000
CY2021Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
452000
CY2021Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
461000
CY2021Q2 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
1410000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
45000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
95000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
106000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
116000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
123000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
64000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
549000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
115000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
434000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0935

Files In Submission

Name View Source Status
0000926617-21-000069-index-headers.html Edgar Link pending
0000926617-21-000069-index.html Edgar Link pending
0000926617-21-000069.txt Edgar Link pending
0000926617-21-000069-xbrl.zip Edgar Link pending
awh-20210630.xsd Edgar Link pending
awh-20210630x10q.htm Edgar Link pending
awh-20210630x10q_htm.xml Edgar Link completed
awh-20210630xex31_1.htm Edgar Link pending
awh-20210630xex31_2.htm Edgar Link pending
awh-20210630xex32_1.htm Edgar Link pending
awh-20210630_cal.xml Edgar Link unprocessable
awh-20210630_def.xml Edgar Link unprocessable
awh-20210630_lab.xml Edgar Link unprocessable
awh-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending